hard · Corporate Credit Analysis
A sponsor-backed LBO company has an 'Equity Cure' provision. After a bad quarter, EBITDA falls to $150M, causing leverage to hit 6.5x against a 6.0x covenant on $1.05B of debt.
If the sponsor injects $30M in cash as a cure, how is the covenant test recalculated?
- The $30M reduces debt to $1.02B, but EBITDA remains $150M
- The leverage remains 6.5x but the breach is waived
- The $30M is added to EBITDA, reducing the test ratio to 5.83x
- The $30M is multiplied by the leverage ratio to find the required EBITDA
Sign up free to see the explanation and track your rank →
More Corporate Credit Analysis practice
- Apex Manufacturing has a total exposure at default (EAD) of… — What is the annual expected
- What is the company's Funds From Operations (FFO)?
- Which statement best reflects the credit risk synthesis?
- A credit agreement requires a borrower to maintain a Net Lev… — What type of covenant is t
- Using the Merton structural model intuition, if a company's equity volatility (sigma_V) in
- What is its CET1 ratio?
- If EBITDA is $150M, what is the entry leverage multiple?
- What is its EBITDA/Interest coverage ratio?